postibrutinib 1
outcomes 1
patients 2
mantle 1
cell 1
lymphoma 2
bendamustine 1
rituximabrefractory 1
indolent 1
transformed 1
nonhodgkins 1
results 1
phase 1
ii 1
multicenter 1
singleagent 1
study 1
